1. Metabolomics and Biomarkers for Paroxysmal and Persistent Atrial Fibrillation
- Author
-
Li‐Li Zhang, Wen‐Hua Lin, Cheng‐Ye Di, Hai‐Tao Hou, Huan‐Xin Chen, Jie Zhou, Qin Yang, and Guo‐Wei He
- Subjects
atrial fibrillation ,metabolites ,metabolomics ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Atrial fibrillation (AF) is the most common type of arrhythmia worldwide and is associated with serious complications. This study investigated the metabolic biomarkers associated with AF and the differences in metabolomics and associated metabolic biomarkers between paroxysmal AF (AFPA) and persistent AF. Methods and Results Plasma samples were prospectively collected from patients with AF and patients in sinus rhythm with negative coronary angiography. The patients were divided into 3 groups: AFPA, persistent AF, and sinus rhythm (N=54). Metabolomics (n=36) using ultra‐high‐performance liquid chromatography mass spectrometry was used to detect differential metabolites that were validated in a new cohort (n=18). The validated metabolites from the validation phase were further analyzed by receiver operating characteristic. Among the 36 differential metabolites detected by omics assay, 4 were successfully validated with area under the curve >0.8 (P
- Published
- 2024
- Full Text
- View/download PDF